Targeting PD‐L1 with DNA Aptamers and Conjugated with Gemcitabine as a Novel Therapeutic Strategy for Bladder Cancer Chemotherapy Combined with Immunotherapy

利用DNA适体靶向PD-L1并与吉西他滨偶联,作为一种新型膀胱癌化疗联合免疫疗法的治疗策略

阅读:1

Abstract

NH(3) plays an indispensable role in agriculture, fertilizer production as well as in the chemical industry. However, its large-scale production still relies deeply on the century-old Haber-Bosch process under high temperature and pressure along with greenhouse gas emission and fossil fuel consumption. The electrocatalytic and photocatalytic N(2) reduction reactions (NRRs) for NH(3) production are favorable approaches to avoid these issues because they are carbon-neutral and energy-saving. Recently, the nonprecious metal oxides (NPMO) have gathered the most attention due to their ease of synthesis, controllable stability, lower cost, and environmental friendliness. Herein, the recent advances in NPMO electrocatalysts and photocatalysts for the NRR are narrated and the strategies to improve the poor NRR activity of pristine NPMOs by heteroatom doping to engineer their surface-active sites and introduction of oxygen vacancies are highlighted. A brief summary of and the future perspective on this research field are also presented.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。